Expanding access to HCV prevention, testing, and treatment in prisons: Recommendations from the INHSU 2022 Prisons Workshop (Co-convened by the Coalition for Global Hepatitis Elimination & INHSU Prisons)

Expanding access to HCV prevention, testing, and treatment in prisons: Recommendations from the INHSU 2022 Prisons Workshop (Co-convened by the Coalition for Global Hepatitis Elimination & INHSU Prisons)

March 21 2023
04:30 PM
Webinar series
HCV in Prisons
Prisons Webinar Digital Flyer

In October 2022, INHSU Prisons and the Coalition for Global Hepatitis Elimination (CGHE) convened a workshop on the strategies for expanding access to hepatitis C virus (HCV) prevention, testing, and treatment in prison settings. The workshop put forward a call to action with recommendations on how to practically overcome barriers to HCV care and accelerate progress toward HCV elimination for those who are incarcerated.

This webinar will continue the dialogue on ensuring the right to access HCV services for persons who are incarcerated. Join us for two engaging panel discussions on addressing the key policy and financing roadblocks to expanding HCV care for persons who are incarcerated and what models of HCV testing and treatment are most effective in prison settings.  

A workshop report will be launched during the webinar. 

REGISTER HERE

 

The program includes:

  • Welcome | John Ward, Coalition for Global Hepatitis Elimination 
  • Setting the stage & overview of 2022 INHSU workshop | John Ward and Andrew Lloyd, INHSU Prisons 
  • Panel 1: How can we address the key policy and financing roadblocks to expanding HCV care in prisons? | Moderators: John Ward & Andrew Lloyd
    • Luke Grant | Corrective Services New South Wales, Australia 
    • Anthony James | Louisiana Office of Public Health STD/HIV/Hepatitis Program, United States
    • Jean Schexnayder | Louisiana Office of Public Health STD/HIV/Hepatitis Program,, United States
    • Kathryn Barthe | Louisiana Office of Public Health STD/HIV/Hepatitis Program,, United States
    • Risha Irvin | Johns Hopkins University, United States 
    • Nonso Maduka | Bensther Development Foundation, Nigeria
    • Antons Mozalevskis | World Health Organization
  • Panel 2: What models of HCV testing and treatment are most effective in the prison setting? | Moderators: Matt Akiyama, Albert Einstein College of Medicine and Montefiore Medical Center, United States & Nadine Kronfli, McGill University Health Centre, Canada
    • Lee Christensen |  Hepatitis C Trust, England
    • Joaquin Cabezas | Marques de Valdecilla University Hospital, Spain
    • Lise Lafferty | University of New South Wales, Australia
    • Sharon Hutchinson | Glasgow Caledonian University, Scotland
    • Julia Sheehan | Hepatitis C Trust, England
    • Antons Mozalevskis | World Health Organization
  • Wrap-up

Contact Lindsey Hiebert, Associate Director of the Coalition for Global Hepatitis Elimination, at lhiebert [at] taskforce.org for more information